TCL Archive NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial. August 10, 2007
TCL Archive BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions July 4, 2014
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget April 30, 1999
